Palliative Radiotherapy During the Last Month of Life: Have COVID-19 Recommendations Led to Reduced Utilization?
In Vivo
; 35(1): 649-652, 2021.
Article
in English
| MEDLINE | ID: covidwho-1011858
ABSTRACT
BACKGROUND/AIM:
The study aimed to evaluate practice changes in the time period of the early wave of the COVID-19 pandemic. PATIENTS ANDMETHODS:
This was a retrospective single institution study. We defined palliative radiotherapy (PRT) initiated before Saturday, March 14th as pre-COVID and PRT initiated later as during-COVID (through June 30th).RESULTS:
National COVID-19 recommendations led to a significant decrease in PRT with 10 or more fractions, while re-irradiation and radiotherapy during the final 30 days of life were equally common before and after these recommendations had been issued in March 2020.CONCLUSION:
Rapid adoption of modified PRT regimens was feasible. However, the challenge of overtreatment in the final phase of the disease, due to inaccurate survival prediction, persisted.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Palliative Care
/
SARS-CoV-2
/
COVID-19
/
Neoplasms
Type of study:
Experimental Studies
/
Observational study
/
Prognostic study
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
English
Journal:
In Vivo
Journal subject:
Neoplasms
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS